Veritas Pharma Inc.
Veritas has developed intellectual property and clinical data relating to various cannabis strains and products. It is the Company’s aim to advance the science behind medicinal cannabis, by developing cannabis-based treatments for specific disease conditions. The Company is also focused on investigating opportunities to acquire income-producing assets in the cannabis industry. Moreover, Veritas intends to leverage its management expertise to enter into mergers and acquisitions with suitable cannabis-industry participants, with a view to generating revenue while continuing its research and development opportunities.
Veritas Pharma Inc. (VRT)
Le 9 septembre/September 2021
Effective immediately, Veritas Pharma Inc. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
À compter de maintenant Veritas Pharma Inc. sera rétablie à des fins de négociation.
La Société a rectifié la situation de défaut ayant donné lieu à la suspension.